Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Slides:

Advertisements

Similar presentations

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Advertisements

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

True Negative Predictive Value of Endobronchial Ultrasound in Lung Cancer: Are We Being Conservative Enough? Bryan A. Whitson, MD, PhD, Shawn S. Groth,

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Endobronchial Ultrasonography for Positron Emission Tomography and Computed Tomography–Negative Lymph Node Staging in Non-Small Cell Lung Cancer Masato.

Complete Metabolic Response Is Not Uniformly Predictive of Complete Pathologic Response After Induction Therapy for Esophageal Cancer Brendon M. Stiles,

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Ivan H. W. Yim, BS, MBBS, Malcolm B

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,

The True False Negative Rates of Esophageal and Endobronchial Ultrasound in the Staging of Mediastinal Lymph Nodes in Patients With Non-Small Cell Lung.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

An Evidence-Based Estimate on the Size of the Potential Patient Pool for Lung Volume Reduction Surgery Praveen Akuthota, MD, Diana Litmanovich, MD, Moshe.

Clinical Significance of Spontaneous Pneumomediastinum

When is it Best to Repeat a 2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Scan on Patients with Non-Small Cell Lung Cancer.

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Mohamed K. Kamel, MD, Mohamed Rahouma, MD, Benjamin Lee, MD, Sebron W

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients David C. Chang, PhD,

Positron Emission Tomography-Computed Tomography for Postoperative Surveillance in Non-Small Cell Lung Cancer Se Hoon Choi, MD, Young Tae Kim, MD, PhD,

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Coexistent Pulmonary Inflammatory Pseudotumor and Carcinoma in One Patient: Does Positron Emission Tomography/Computed Tomography Help Zhi Zheng, MD,

Lung Cancer Surgery in Patients With Liver Cirrhosis

Daniel H. Buitrago, MD, MPH, Sidhu P

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Who Do You Say You Are? The Annals of Thoracic Surgery

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer Stephen A. Barnett, MBBS, Robert.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Thymic and Mediastinal Lymph Node Metastasis of Colon Cancer

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Results of Superior Vena Cava Reconstruction With Externally Stented- Polytetrafluoroethylene Vascular Prostheses Ikenna C. Okereke, MD, Kenneth A. Kesler,

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Pulmonary Resection for Lung Cancer in Octogenarians

Open, Video-Assisted Thoracic Surgery, and Robotic Lobectomy: Review of a National Database Michael Kent, MD, Thomas Wang, PhD, Richard Whyte, MD, Thomas.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Differentiating N0 Versus N1 Lung Cancer Kazuhiro Yasufuku, MD, PhD, Takahiro Nakajima,

Bronchopulmonary Carcinoid Tumor Presenting With Polymyositis

Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant? Daniel J. Tandberg,

Editorial Board, January 2010

Surgical Treatment for Limited-Stage Primary Small Cell Cancer of the Esophagus Dongrong Situ, MD, Yongbin Lin, MD, PhD, Hao Long, MD, PhD, Lanjun Zhang,

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Kemp H Kernstine, MD, PhD, Kelley A McLaughlin,

Lymph Node Staging by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Patients With Small Cell Lung Cancer Hironobu Wada, MD, Takahiro.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Invited Commentary The Annals of Thoracic Surgery

Neal S Goldstein, MD The Annals of Thoracic Surgery

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Andrew Auerbach, MD, David H. Roberts, MD, Sidhu P

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Lung Cancer Invading the Pericardium: Quantum of Lymph Nodes

Meghan R. Flanagan, MD, Thomas K. Varghese, MD, MS, Leah M

Presentation transcript:

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer Ikenna C. Okereke, MD, Sidhu P. Gangadharan, MD, Michael S. Kent, MD, Saila P. Nicotera, MD, Changyu Shen, PhD, Malcolm M. DeCamp, MD The Annals of Thoracic Surgery Volume 88, Issue 3, Pages 911-916 (September 2009) DOI: 10.1016/j.athoracsur.2009.05.083 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Positron emission tomography (PET) stage versus survival. The Annals of Thoracic Surgery 2009 88, 911-916DOI: (10.1016/j.athoracsur.2009.05.083) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Standardized uptake value of the primary mass (SUV-T) versus survival. The Annals of Thoracic Surgery 2009 88, 911-916DOI: (10.1016/j.athoracsur.2009.05.083) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Standardized uptake value of the regional lymph nodes (SUV-N) versus survival. The Annals of Thoracic Surgery 2009 88, 911-916DOI: (10.1016/j.athoracsur.2009.05.083) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Survival in mediastinum-negative patients. (SUV = standardized uptake value.) The Annals of Thoracic Surgery 2009 88, 911-916DOI: (10.1016/j.athoracsur.2009.05.083) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions